CAIX inhibitors are designed to block the enzyme activity of CAIX, thereby disrupting the pH regulation critical for cancer cell survival. This can lead to:
Increased intracellular acidity, causing cancer cell death. Reduced invasion and metastasis of cancer cells. Enhanced sensitivity to other cancer treatments, including chemotherapy and radiation therapy.
